Development of type 1 diabetes in a patient treated with anti-TNF-alpha therapy for active rheumatoid arthritis

Diabetologia. 2009 Jul;52(7):1442-4. doi: 10.1007/s00125-009-1381-0. Epub 2009 May 14.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Diabetes Mellitus, Type 1 / chemically induced*
  • Diabetes Mellitus, Type 1 / immunology
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / adverse effects*
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept